These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20572087)

  • 21. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
    Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
    Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K; Degertekin H; Bahcecioglu IH; Demir A; Aladag M; Yildirim B; Horasanli S; Ciftci S; Badur S
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of hepatic fibrosis and necroinflammation among inactive HBsAg carriers in Egypt.
    Fateen AA; Shahin RY; Farres MN; Eldeeb MA; Amer HA
    Ann Hepatol; 2012; 11(4):464-70. PubMed ID: 22700627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
    Park JY; Park YN; Kim DY; Paik YH; Lee KS; Moon BS; Han KH; Chon CY; Ahn SH
    J Viral Hepat; 2008 Aug; 15(8):615-21. PubMed ID: 18573162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship among pathological changes in Liver tissues and level of serum HBV DNA, HBeAg and ALT of 194 patients with chronic hepatitis B].
    Zhao DY; Qin YQ; Tang XM; Liu GZ; Zheng W; Nong HR; Song JJ; Xie QY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):35-7. PubMed ID: 17429530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Liver pathological changes and clinical features of patients with chronic hepatitis B virus infection in their immune tolerant phase and non-active status].
    Li J; Zhao GM; Zhu LM; Li Y; Xin SJ
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):326-9. PubMed ID: 17524261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH; Shu X; Chen LB; Huang HH; Zhang K; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum.
    Mariscal LF; Rodríguez-Iñigo E; Bartolomé J; Castillo I; Ortiz-Movilla N; Navacerrada C; Pardo M; Pérez-Mota A; Graus J; Carreño V
    J Med Virol; 2004 Jun; 73(2):177-86. PubMed ID: 15122790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An analysis of the pathohistology of liver tissues, clinical features and prognostic factors of chronic hepatitis B virus carriers].
    Wu CH; Si CW; Tian GS; Yu YY; Xu XY; Wang TL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):577-81. PubMed ID: 17711625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. e-antigen-negative chronic hepatitis B in Bangladesh.
    Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
    Chu CJ; Hussain M; Lok AS
    Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
    Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
    Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
    Zhu R; Huang H; Zhang H; Wang Z; Hu X; Zhai W; Lin Y; Wang J; Zhu H
    Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study on the hepatic histological changes and clinical manifestations in chronic HBV carriers].
    Wei N; Yang D; Yang F; Wang Y; Zhao B; Lü DG
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):330-3. PubMed ID: 17524262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.
    Mohamadnejad M; Montazeri G; Fazlollahi A; Zamani F; Nasiri J; Nobakht H; Forouzanfar MH; Abedian S; Tavangar SM; Mohamadkhani A; Ghoujeghi F; Estakhri A; Nouri N; Farzadi Z; Najjari A; Malekzadeh R
    Am J Gastroenterol; 2006 Nov; 101(11):2537-45. PubMed ID: 17029616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
    Chu CM; Liaw YF
    Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.